ICU Medical, Inc. engages in the provision of innovative medical products used in infusion therapy and critical care applications. The company is headquartered in San Clemente, California and currently employs 13,000 full-time employees. Its product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needlefree IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its Infusion Therapy products include Clave needlefree products, Neutron, ClearGuard, and Tego. Its oncology products include ChemoLock Closed System Transfer Devices (CSTD) and Deltec GRIPPER non-coring needles for portal access. Its vascular access products include Safe-T Wing venipuncture and blood collection devices; Port-A-Cath implantable port, and Portex arterial blood sampling syringes. Its Tracheostomy products include Portex BLUselect PVC tracheostomy tubes.
Mr. Vivek Jain est le Chairman of the Board de ICU Medical Inc, il a rejoint l'entreprise depuis 2014.
Quelle est la performance du prix de l'action ICUI ?
Le prix actuel de ICUI est de $129.93, il a diminué de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de ICU Medical Inc ?
ICU Medical Inc appartient à l'industrie Health Care et le secteur est Health Care
Quel est la capitalisation boursière de ICU Medical Inc ?
La capitalisation boursière actuelle de ICU Medical Inc est de $3.2B
Est-ce que ICU Medical Inc est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 7 analystes ont établi des notations d'analystes pour ICU Medical Inc, y compris 4 achat fort, 6 achat, 2 maintien, 0 vente et 4 vente forte